Literature DB >> 9671394

Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene.

Y Sekido1, M Ahmadian, I I Wistuba, F Latif, S Bader, M H Wei, F M Duh, A F Gazdar, M I Lerman, J D Minna.   

Abstract

Chromosome 3p abnormalities and allele loss are frequent in lung and breast cancers, and several lung cancer cell lines exhibit homozygous deletions of 3p indicating potential sites of tumor suppressor genes at regions 3p21.3, 3p14.2 and 3p12. We have identified and characterized a new 3p21.3 homozygous deletion in a breast cancer cell line and the primary tumor that overlaps those previously described in small cell lung cancer (SCLC). This homozygous deletion is approximately 220 kb in length and represents a somatically acquired change in the primary breast cancer. Cloning and sequencing of the breakpoint demonstrated that this resulted from an interstitial deletion and precisely pinpoints this deletion within the three SCLC homozygous deletions previously reported. This deletion significantly narrows the minimum common deleted region to 120 kb and is distinct from the previously reported region that suppresses tumor formation of the murine A9 fibrosarcoma cells. These findings suggest that a common homozygous deletion region on 3p21.3 is important in both lung and breast cancers. It is likely that this very well characterized region either contains one tumor suppressor gene common to both tumor types or two closely linked tumor suppressor genes specific for each tumor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671394     DOI: 10.1038/sj.onc.1201858

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  28 in total

1.  New transformation tricks from a barnyard retrovirus: implications for human lung cancer.

Authors:  N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines.

Authors:  Erika da Costa Prando; Luciane Regina Cavalli; Cláudia Aparecida Rainho
Journal:  Epigenetics       Date:  2011-12       Impact factor: 4.528

3.  High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss.

Authors:  A Maitra; I I Wistuba; C Washington; A K Virmani; R Ashfaq; S Milchgrub; A F Gazdar; J D Minna
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.

Authors:  Karen S Yee; Lukasz Grochola; Garth Hamilton; Anna Grawenda; Elisabeth E Bond; Helge Taubert; Peter Wurl; Gareth L Bond; Eric O'Neill
Journal:  Cancer Res       Date:  2012-03-02       Impact factor: 12.701

Review 5.  Mouse chromosome engineering for modeling human disease.

Authors:  Louise van der Weyden; Allan Bradley
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

6.  Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo.

Authors:  Lin Ji; Masahiko Nishizaki; Boning Gao; David Burbee; Masashi Kondo; Craig Kamibayashi; Kai Xu; Nancy Yen; E Neely Atkinson; Bingliang Fang; Michael I Lerman; Jack A Roth; John D Minna
Journal:  Cancer Res       Date:  2002-05-01       Impact factor: 12.701

7.  Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation.

Authors:  S K Rai; F M Duh; V Vigdorovich; A Danilkovitch-Miagkova; M I Lerman; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

8.  Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis.

Authors:  A Martinez; P Fullwood; K Kondo; T Kishida; M Yao; E R Maher; F Latif
Journal:  Mol Pathol       Date:  2000-06

9.  The tumor suppressor RASSF1A is a novel effector of small G protein Rap1A.

Authors:  Sunil K Verma; Trivadi S Ganesan; Uday Kishore; Peter J Parker
Journal:  Protein Cell       Date:  2011-04-06       Impact factor: 14.870

10.  Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma.

Authors:  Angelo Agathanggelou; Ivan Bièche; Jalal Ahmed-Choudhury; Barbara Nicke; Reinhard Dammann; Shairaz Baksh; Boning Gao; John D Minna; Julian Downward; Eamonn R Maher; Farida Latif
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.